CLOUDBREAK THERAPEUTICS LLC SBIR Phase II Award, September 2020
A SBIR Phase II contract was awarded to CLOUDBREAK THERAPEUTICS LLC in September, 2020 for $699,988.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.